Krystal Biotech Newsroom

Krystal Biotech Is Maintained at Neutral by Citigroup

Dow JonesNov 5 22:59

HC Wainwright & Co. Reiterates Buy on Krystal Biotech, Maintains $221 Price Target

BenzingaNov 5 22:40

A Quick Look at Today's Ratings for Krystal Biotech(KRYS.US), With a Forecast Between $206 to $221

Futu NewsNov 5 21:07

Krystal Biotech's Strong Financial Performance and Strategic Advancements Drive Buy Rating

TipRanksNov 5 00:29

Stifel Maintains Krystal Biotech(KRYS.US) With Buy Rating, Raises Target Price to $220

Futu NewsOct 1 19:35

Stifel Nicolaus Remains a Buy on Krystal Biotech (KRYS)

TipRanksOct 1 19:09

Krystal Biotech Is Maintained at Buy by Stifel

Dow JonesSep 11 19:53

Krystal Biotech Analyst Ratings

BenzingaSep 11 19:44

Stifel Maintains Krystal Biotech(KRYS.US) With Buy Rating, Announces Target Price $204

Futu NewsSep 10 20:31

Krystal Biotech (KRYS) Receives a Buy From TD Cowen

TipRanksAug 30 19:37

TD Cowen Maintains Krystal Biotech(KRYS.US) With Buy Rating, Maintains Target Price $208

Futu NewsAug 30 19:33

H.C. Wainwright Maintains Krystal Biotech(KRYS.US) With Buy Rating, Maintains Target Price $221

Futu NewsAug 29 18:32

Krystal Biotech Analyst Ratings

BenzingaAug 29 01:29

H.C. Wainwright Maintains Krystal Biotech(KRYS.US) With Buy Rating, Raises Target Price to $221

Futu NewsAug 28 23:31

Buy Rating Affirmed for Krystal Biotech Following Promising KB301 Study Results

TipRanksAug 28 23:17

HC Wainwright Adjusts Krystal Biotech Price Target to $221 From $200, Maintains Buy Rating

MT NewswiresAug 28 23:07

Stifel Maintains Krystal Biotech(KRYS.US) With Buy Rating

Futu NewsAug 28 22:31

Stifel Nicolaus Keeps Their Buy Rating on Krystal Biotech (KRYS)

TipRanksAug 28 22:00

Evercore ISI Lifts Price Target on Krystal Biotech to $206 From $201, Keeps Outperform Rating

MT NewswiresAug 26 19:28

Evercore ISI Group Maintains Outperform on Krystal Biotech, Raises Price Target to $206

BenzingaAug 12 22:02